Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

Exclusion Criteria

• •The sitting DBP is more than 110mmHg or the sitting SBP over 180mmHg
• •Patients with postural hypotension
• •Patients with severe renal(Creatinine more 1.5mg/dl), gastrointestinal, hematological or hepatic(AST, ALT more 3 times more than upper limit of normal)disease
• •Female of childbearing potential who does not undergo hysterectomy or is not post-menopausal
• •Patients judged to have a history of alcohol or drug abuse by the investigator
• •Patients with a history of myocardial infarction, severe coronary artery disease or clinically significant heart failure or valvular defect in last 6 months
• •Patients with uncontrolled diabetes mellitus
• •Patients participated other clinical trial 12 weeks before Screening Patients judged to be inappropriate for this study by the investigator with other reasons